Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • KING PHARMACEUTICALS INC Financial Overview

  • Income Statement: KG

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 1.57 B 2.14 B -571.82 M -36.54%
    Gross Profit 1.02 B 1.40 B -380.76 M -37.35%
    Net Income Before Extra Items/Preferred Div -333.06 M 182.98 M -516.04 M 154.94%
    Operating Income 428.33 M 558.53 M -130.20 M -30.40%
  • Cash Flow: KG

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 584.92 M 9.83 M 575.09 M 98.32%
    Net Cash Flow - Investing 156.11 M 776.25 M -620.14 M -397.25%
    Net Cash Flow/Operating Activities 491.39 M 672.65 M -181.26 M -36.89%
  • Balance Sheet: KG

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 3.95 B 3.08 B 870.85 M 22.02%
    Total Liabilities 1.78 B 572.36 M 1.20 B 67.78%
    Shareholders Equity 2.18 B 2.51 B -333.43 M -15.31%
  • Key Ratios / Statistics: KG

    • Valuation

      Price/Earnings (TTM) -7.75
      Price/Sales (TTM) 1.65
      Price/Book (MRQ) 1.14
      Price/Cash Flow (TTM) 4.74
    • Profitability

      Gross Margin 65.14
      Operating Margin 27.37
      Profit Margin -21.28
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.18
      Current Ratio (MRQ) 2.23
      Long Term Debt-to-Equity (MRQ) 21.66
    • Management Effectiveness

      Return on Equity (TTM) -14.40
      Return on Assets (TTM) -13.48
      Return on Investments (TTM) -10.10